European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

Item
http://www.wikidata.org/entity/Q35051720
Changing Treatment May Affect the Predictive Ability of European Treatment Outcome Study Scoring for the Prognosis of Patients with Chronic Myeloid Leukemia.Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia.Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapyCombination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients.The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution ExperiencePrognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India.Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.Improved prediction of clinical outcome in chronic myeloid leukemia.Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy.Predictive parameters for imatinib failure in patients with chronic myeloid leukemia.Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib.The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia.Prognostic discrimination for early chronic phase chronic myeloid leukemia in imatinib era: comparison of Sokal, Euro, and EUTOS scores in Korean population.Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib
P2860

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

Item
http://www.wikidata.org/entity/Q35051720
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
European Treatment and Outcome ...... onic myeloid leukemia patients
@ast
European Treatment and Outcome ...... onic myeloid leukemia patients
@en
type
label
European Treatment and Outcome ...... onic myeloid leukemia patients
@ast
European Treatment and Outcome ...... onic myeloid leukemia patients
@en
prefLabel
European Treatment and Outcome ...... onic myeloid leukemia patients
@ast
European Treatment and Outcome ...... onic myeloid leukemia patients
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
European Treatment and Outcome ...... onic myeloid leukemia patients
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932